BioTrack Capital
Finance · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
兴业太古汇香港兴业中心一座 288号 石门一路 层 6 601-602室, Sh...Website
www.biotrackcapital.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BioTrack Capital
Founded in 2017, BioTrack Capital is a dedicated healthcare venture capital firm focused on building and incubating innovative life science companies in China. We continually seek to discover innovative biotech companies, innovative medtech companies, and innovative business models in healthcare which are led by outstanding entrepreneurs.Explore more
Popular SearchesBiotrack Capital博远资本SIC Code 67,679NAICS Code 52,523Show moreBioTrack Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioTrack Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if BioTrack Capital is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at BioTrack Capital
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once BioTrack Capital has new funding data
Click to see if BioTrack Capital had a recent Job posting/layoffs
Earning: See what the market has to say on BioTrack Capital recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if BioTrack Capital has recently received funding, and reach out quickly before it becomes old news!
BioTrack Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when BioTrack Capital launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
BioTrack Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
BioTrack Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about BioTrack Capital.
BioTrack Capital Tech Stack
A closer look at the technologies used by BioTrack Capital
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
BioTrack Capital News & Media
Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
BioTrack Capital and Yonjin Capital join Series A round alongside other investors including 3E Bioventures Capital, Proxima Ventures Ltd., and Lapam CapitalPAQ Therapeutics Raises $39M in Series B Financing
PAQ Therapeutics, a Burlington, MA-based biotechnology company developing KRAS degraders, raised $39M in Series B funding. The round was led by Bayland Capital and MRL Ventures Fund (MRLV), with participation from Johnson & Johnson Innovation – JJDC, Inc. (JJDC), LAV Fund, BioTrack Capital, and existing investor Sherpa Health Partners. The company intends to use the […] The post PAQ Therapeutics Raises $39M in Series B Financing appeared first on FinSMEs.Cargene Closes a US$19.2M Pre-A Round Led by BioTrack Capital
Accelerating nucleic acid therapeutics through innovative chemistry and biology to improve lives worldwide SINGAPORE and SHANGHAI and BOSTON, Dec. 14, 2021 /PRNewswire/ -- Cargene Biopharma Inc. ("Cargene") announced today the close of an over-subscribed US$19.2 million pre-Series A funding round. The financing was led by BioTrack Capital, with participation from Hyfinity Investments, Legendstar Capital and other investors. Cargene is a preclinical-stage biopharmaceutical company developing oligCarcell Biopharma closes an oversubscribed financing round led by Hyfinity Investments
SINGAPORE, Nov. 1, 2021 /PRNewswire/ -- Carcell Biopharma ("Carcell", the "Company") announced today the close of an over-subscribed financing. The round was led by Hyfinity Investments, with participation from BioTrack Capital, Legendstar Capital and other investors. Carcell Biopharma is...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding BioTrack Capital
Sign Up For FreeTo access detailed company insights
Founded in 2017, BioTrack Capital is a dedicated healthcare venture capital firm focused on building and incubating innovative life science companies in China. We continually seek to discover innovative biotech companies, innovative medtech companies, and innovative business models in healthcare which are led by outstanding entrepreneurs.... Read More
